Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
35.1M
-
Shares change
-
+310K
-
Total reported value, excl. options
-
$2.45B
-
Value change
-
+$23.2M
-
Put/Call ratio
-
0.47
-
Number of buys
-
90
-
Number of sells
-
-54
-
Price
-
$69.99
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2014
179 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2014.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.1M shares
of 44.9M outstanding shares and own 78.16% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (4.65M shares), GILDER GAGNON HOWE & CO LLC (3.41M shares), FMR LLC (3.14M shares), JENNISON ASSOCIATES LLC (2.63M shares), VANGUARD GROUP INC (1.96M shares), DARUMA CAPITAL MANAGEMENT LLC (1.37M shares), BlackRock Fund Advisors (1.24M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.2M shares), Visium Asset Management, LP (1.03M shares), and MARSICO CAPITAL MANAGEMENT LLC (942K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.